Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 5Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 977INDUSTRY 180OTHER_GOV 47NIH 10NETWORK 6UNKNOWN 5FED 3INDIV 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 1Lymphoid 1Head & Neck 1

Conditions

Breast Neoplasms 33Esophageal Neoplasms 14Stomach Neoplasms 11Rectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Triple Negative Breast Neoplasms 8Colorectal Neoplasms 8Small Cell Lung Carcinoma 7Lung Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Brain Neoplasms 6Neoplasms 5Esophageal Squamous Cell Carcinoma 5Recurrence 3Nasopharyngeal Carcinoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3Head and Neck Neoplasms 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Radiation Injuries 2Papillomavirus Infections 2Carcinoma, Small Cell 2Carcinoma, Hepatocellular 2

Interventions

apatinib 1Sunitinib 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Neoplasms × Clear all
NCT03731390 2018-11-06

GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma

ChineseAMS

Phase 1 Unknown
30 enrolled
Lymphoid

Lymphoma, Neoplasms

NCT03412344 2018-01-26

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

ChineseAMS

Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

NCT03199677 2017-07-02

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

ChineseAMS

Phase 2 Unknown
40 enrolled
Head & Neck

Neoplasms, Thyroid Neoplasms

NCT03039062 2017-03-30

Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy

ChineseAMS

Unknown
180 enrolled
Tumor-Agnostic

Neoplasms

NCT01850147 2013-05-09

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

ChineseAMS

Phase 2 Unknown
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡